Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years?

Xu XL, Gou WL, Wang AY, Wang Y, Guo QY, Lu Q, Lu SB, Peng J.

J Transl Med. 2013 Dec 11;11:303. doi: 10.1186/1479-5876-11-303.

PMID:
24330728
[PubMed - in process]
Free PMC Article
2.

A novel monthly dosing regimen of risedronate for the treatment of postmenopausal osteoporosis: 2-year data.

McClung MR, Benhamou CL, Man Z, Tlustochowicz W, Zanchetta JR, Eusebio R, Balske AM, Matzkin E, Olszynski WP, Recker R, Delmas PD.

Calcif Tissue Int. 2013 Jan;92(1):59-67. doi: 10.1007/s00223-012-9668-4. Epub 2012 Nov 13.

PMID:
23150144
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.

Body JJ, Bergmann P, Boonen S, Devogelaer JP, Gielen E, Goemaere S, Kaufman JM, Rozenberg S, Reginster JY.

Osteoporos Int. 2012 Feb;23 Suppl 1:S1-23. doi: 10.1007/s00198-011-1891-8. Epub 2012 Feb 4.

PMID:
22311111
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Risedronate's Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis.

Gates BJ, Das S.

Clin Med Insights Arthritis Musculoskelet Disord. 2012;5:1-14. doi: 10.4137/CMAMD.S4092. Epub 2012 Jan 5.

PMID:
22267947
[PubMed]
Free PMC Article
5.

A rare case of zolendronate infusion complication leading to glaucoma filtration surgery.

Khan A, Lascaratos G, Rane-Malcolm T, Sanders R.

Clin Ophthalmol. 2011;5:1147-9. doi: 10.2147/OPTH.S22429. Epub 2011 Aug 18.

PMID:
21887097
[PubMed]
Free PMC Article
6.

Intravenous bisphosphonate therapy and atrial fibrillation/flutter risk in cancer patients: a nationwide cohort study.

Erichsen R, Christiansen CF, Frøslev T, Jacobsen J, Sørensen HT.

Br J Cancer. 2011 Sep 27;105(7):881-3. doi: 10.1038/bjc.2011.338. Epub 2011 Aug 30.

PMID:
21878939
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.

Rizzoli R, Reginster JY, Boonen S, Bréart G, Diez-Perez A, Felsenberg D, Kaufman JM, Kanis JA, Cooper C.

Calcif Tissue Int. 2011 Aug;89(2):91-104. doi: 10.1007/s00223-011-9499-8. Epub 2011 Jun 3. Review.

PMID:
21637997
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Atrial fibrillation and the use of oral bisphosphonates.

Pazianas M, Cooper C, Wang Y, Lange JL, Russell RG.

Ther Clin Risk Manag. 2011;7:131-44. doi: 10.2147/TCRM.S17899. Epub 2011 Mar 22.

PMID:
21479144
[PubMed]
Free PMC Article
9.

Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials.

Barrett-Connor E, Swern AS, Hustad CM, Bone HG, Liberman UA, Papapoulos S, Wang H, de Papp A, Santora AC.

Osteoporos Int. 2012 Jan;23(1):233-45. doi: 10.1007/s00198-011-1546-9. Epub 2011 Mar 3.

PMID:
21369791
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.

Pazianas M, Cooper C, Ebetino FH, Russell RG.

Ther Clin Risk Manag. 2010 Jul 21;6:325-43.

PMID:
20668715
[PubMed]
Free PMC Article
11.

Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis.

Serefoglu EC, Tandogdu Z.

Ther Clin Risk Manag. 2010 May 25;6:219-23.

PMID:
20526439
[PubMed]
Free PMC Article
12.

Bisphosphonates and risk of atrial fibrillation: a meta-analysis.

Kim SY, Kim MJ, Cadarette SM, Solomon DH.

Arthritis Res Ther. 2010;12(1):R30. doi: 10.1186/ar2938. Epub 2010 Feb 19.

PMID:
20170505
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Prevention of osteoporosis-related fractures among postmenopausal women and older men.

Rahmani P, Morin S.

CMAJ. 2009 Nov 24;181(11):815-20. doi: 10.1503/cmaj.080709. Epub 2009 Oct 19. Review. No abstract available.

PMID:
19841053
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies.

Mak A, Cheung MW, Ho RC, Cheak AA, Lau CS.

BMC Musculoskelet Disord. 2009 Sep 21;10:113. doi: 10.1186/1471-2474-10-113.

PMID:
19772579
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Adverse effects of bisphosphonates: implications for osteoporosis management.

Kennel KA, Drake MT.

Mayo Clin Proc. 2009 Jul;84(7):632-7; quiz 638. doi: 10.1016/S0025-6196(11)60752-0. Review.

PMID:
19567717
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture.

Chapurlat RD.

Ther Clin Risk Manag. 2009 Apr;5(2):169-75. Epub 2009 May 4.

PMID:
19536314
[PubMed]
Free PMC Article
17.

Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis.

Grosso A, Douglas I, Hingorani A, MacAllister R, Smeeth L.

PLoS One. 2009;4(3):e4720. doi: 10.1371/journal.pone.0004720. Epub 2009 Mar 6.

PMID:
19266096
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Bisphosphonates: mechanism of action and role in clinical practice.

Drake MT, Clarke BL, Khosla S.

Mayo Clin Proc. 2008 Sep;83(9):1032-45. doi: 10.4065/83.9.1032. Review.

PMID:
18775204
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study.

Sørensen HT, Christensen S, Mehnert F, Pedersen L, Chapurlat RD, Cummings SR, Baron JA.

BMJ. 2008 Apr 12;336(7648):813-6. doi: 10.1136/bmj.39507.551644.BE. Epub 2008 Mar 11.

PMID:
18334527
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Oral bisphosphonates and atrial fibrillation.

Majumdar SR.

BMJ. 2008 Apr 12;336(7648):784-5. doi: 10.1136/bmj.39513.481065.80. Epub 2008 Mar 11. No abstract available.

PMID:
18334526
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk